Back
Janux Therapeutics Stock Price Chart
Sponsored
JANX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
JANX
Janux Therapeutics
Last Price:
50.47
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.67 | Sell |
20-day SMA: | 52.57 | Sell |
50-day SMA: | 49.99 | Sell |
200-day SMA: | 43.49 | Buy |
8-day EMA: | 49.45 | Sell |
20-day EMA: | 50.88 | Sell |
50-day EMA: | 49.72 | Sell |
200-day EMA: | 41.27 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -560247 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.84 - 54.94) | Sell |
Bollinger Bands (100): | (41.05 - 51.21) | Buy |
Janux Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 46.50 while JANX 8-day simple moving average is 49.67, which is a Sell signal.
- The stock price of JANX is 46.50 while Janux Therapeutics 20-day SMA is 52.57, which makes it a Sell.
- Janux Therapeutics 50-day simple moving average is 49.99 while JANX share price is 46.50, making it a Sell technically.
- JANX stock price is 46.50 and Janux Therapeutics 200-day simple moving average is 43.49, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $46.50. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.44B
Price in USD:
46.50
Share Volume:
785.99K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
7.79
Sell
34
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 46.50 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 46.50 while JANX 8-day exponential moving average is 49.45, which is a Sell signal.
- The stock price of JANX is 46.50 while Janux Therapeutics 20-day EMA is 50.88, which makes it a Sell.
- Janux Therapeutics 50-day exponential moving average is 49.72 while JANX share price is 46.50, making it a Sell technically.
- JANX stock price is 46.50 and Janux Therapeutics 200-day simple moving average is 41.27, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.53 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is -0.56, suggesting Janux Therapeutics is a Sell
- Janux Therapeutics Relative Strength Index (RSI) is 33.84, which suggest Janux Therapeutics is oversold
- The Bollinger Bands (25) for Janux Therapeutics is (49.84 - 54.94), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (41.05 - 51.21), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.